Testing effectiveness (Phase 2)Active Not RecruitingNCT06843408
What this trial is testing
A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD
Who this might be right for
Chronic Graft-versus-host-disease
Incyte Corporation 32